GU Liping  

  • Graduate Supervisor, Associate Chief Physician
  • Department: Ultrasound in Medicine
  • Research Area: Medical Technology
  • Research Interests: Ultrasound Diagnostics
  • Contact: guliping666@126.com
  • MD from Xinxiang Medical University, 2009
  • Associate Chief Physician, Department of Ultrasound Medicine, Shanghai Sixth People's Hospital
  1. Zhong Lichang, Yang Tian, Li Pei, Shi Lin, Lai JinYu, Gu Liping. Metal-Organic Framework-Based Nanotherapeutics With Tumor Hypoxia-Relieving Ability for Synergistic Sonodynamic/Chemo-therapy.  Frontiers in Materials, 2022 (9) , doi=10.3389/fmats.2022.841503. 通讯作者
  2. Zhong Lichang, Yang Tian, Lu Feng, et al. Cu(II) Coordination Complex: Anti-Thyroid Carcinoma Activity by Initiating Reactive Oxygen Species Accumulation and Inducing Cell Apoptosis. Journal of Biomedical Nanotechnology, 2022, 18: 1376-1385. 通讯作者
  3. Zhong Lichang, Yang Tian, Gu Liping, Ma Fang. The diagnostic performance of shear wave velocity ratio for the differential diagnosis of benign and malignant breast lesions: Compared with VTQ, and mammography. Clin Hemorheol Microcirc. 2021;77(2):123-131.共同通讯作者
  4. Junxia Cui , Liping Gu, Lichang Zhong, Xuezhu Liu, Yuena Sun, Tianjun Xu . microRNA-20-1 and microRNA-101a Suppress the NF-κB-Mediated Inflammation Production by Targeting TRAF6 in Miiuy Croaker. Infect Immun. 2022 Jan 25;90(1):e0058521.共同第一作者
  5. Shang Geng, Liping Gu, Lichang Zhong, Tianjun Xu, Yuena Sun . Genomic organization, evolution and functional characterization of caspase-2 and caspase-8inmiiuycroaker  (Miichthys miiuy). Dev Comp Immunol. 2022 Feb;127:104308. 共同第一作者
  6. Zhang Jun-An, Gu Liping, Chen Yongqiang, et al.MULTI- FEATURE FUSION EMOTION RECOGNITION BASED ON RESTING EEG.JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY. MAR 2022 共同通讯作者
  • 11/01/2020-10/31/2023
    Project of the Pudong New Area Science, Technology and Economic Development Commission: Establishment and Validation of a Model for Early Prediction of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer Based on Ultrasonic Radiomics and Plasma miRNA-34a (200,000 RMB)      
    Role: Project leader